Psittacosis medical therapy

Jump to navigation Jump to search

Psittacosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Psittacosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Psittacosis medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Psittacosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Psittacosis medical therapy

CDC on Psittacosis medical therapy

Psittacosis medical therapy in the news

Blogs on Psittacosis medical therapy

Psittacosis

Risk calculators and risk factors for Psittacosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The infection is treated with antibiotics. Remission of symptoms usually is evident within 48-72 hours. However, relapse can occur, and treatment must continue for at least 10-14 days after fever abates

Medical therapy

  • Tetracyclines and chloramphenicol are the drugs of choice for treating patients with psittacosis.
  • Most persons respond to:
  • For initial treatment of severely ill patients, doxycycline cyclate may be administered intravenously at a dosage of 4.4 mg/kg (2 mg/lb) body weight per day divided into two infusions per day (up to 100 mg per dose).
  • In past years, tetracycline hydrochloride has been administered to patients intravenously (10-15 mg/kg body weight per day divided into four doses per day).
  • Remission of symptoms usually is evident within 48-72 hours. However, relapse can occur, and treatment must continue for at least 10-14 days after fever abates.
  • Although its in vivo efficacy has not been determined, erythromycin probably is the best alternative agent for persons for whom tetracycline is contraindicated (e.g., children aged less than 9 years and pregnant women).

References

Template:Bacterial diseases

da:Psittacosis de:Ornithose hr:Psitakoza it:Psittacosi no:Papegøyesyke simple:Psittacosis fi:Papukaijakuume sv:Papegojsjuka


Template:WikiDoc Sources